A Double-Blind, Placebo-Controlled, Randomized Trial of Montelukast for Acute Bronchiolitis
Authors:
- 1 December 2008
- journal article
- research article
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 122 (6) , e1249-e1255
Abstract
BACKGROUND. Cysteinyl leukotrienes are implicated in the inflammation of bronchiolitis. Recently, a specific cysteinyl leukotriene receptor antagonist, montelukast (Singulair [MSD, Haarlem, Netherlands]), has been approved for infants in granule sachets. OBJECTIVE. Our goal was to evaluate the effect of montelukast on clinical progress and on cytokines in acute bronchiolitis. METHODS. This was a randomized, placebo-controlled, double-blind, parallel-group study in 2 medical centers. Fifty-three infants (mean age: 3.8 ± 3.5 months) with a first episode of acute bronchiolitis were randomly assigned to receive either 4-mg montelukast sachets or placebo, every day, from hospital admission until discharge. The primary outcome was length of stay, and secondary outcomes included clinical severity score (maximum of 12) and changes in type 1 and 2 cytokine levels (including interleukin4/IFN-γ ratio as a surrogate for the T-helper 2/T-helper 1 ratio) in nasal lavage. RESULTS. Both groups were comparable at baseline, and cytokine levels correlated positively with disease severity. There were neither differences in length of stay (4.63 ± 1.88 [placebo group] vs 4.65 ± 1.97 days [montelukast group]) nor in clinical severity score and cytokine levels between the 2 groups. No differences in interleukin 4/IFN-γ ratio between the 2 groups were seen. There was a slight tendency for infants in the montelukast group to recover more slowly than those in the placebo group (clinical severity score at discharge: 6.1 ± 2.4 vs 4.8 ± 2.2, respectively). CONCLUSIONS. Montelukast did not improve the clinical course in acute bronchiolitis. No significant effect of montelukast on the T-helper 2/T-helper 1 cytokine ratio when given in the early acute phase could be demonstrated.Keywords
This publication has 32 references indexed in Scilit:
- Immunopathogenesis of Respiratory Syncytial Virus BronchiolitisThe Journal of Infectious Diseases, 2007
- Nasal lavage leukotrienes in infants with RSV bronchiolitisPediatric Allergy and Immunology, 2007
- Oral montelukast treatment of preschool-aged children with acute asthmaAnnals of Allergy, Asthma & Immunology, 2006
- The effect of montelukast on lung function and exhaled nitric oxide in infants with early childhood asthmaEuropean Respiratory Journal, 2005
- Eosinophil activation and cysteinyl leukotriene production in infants with respiratory syncytial virus bronchiolitisClinical & Experimental Allergy, 2004
- Bronchiolitis‐Associated Mortality and Estimates of Respiratory Syncytial Virus–Associated Deaths among US Children, 1979–1997The Journal of Infectious Diseases, 2001
- Bronchodilators for bronchiolitis1999
- Dexamethasone in salbutamol-treated inpatients with acute bronchiolitis: A randomized, controlled trialThe Journal of Pediatrics, 1997
- Analysis of cells obtained by bronchial lavage of infants with respiratory syncytial virus infection.Archives of Disease in Childhood, 1994
- Release of leukotriene C4 in respiratory tract during acute viral infectionThe Journal of Pediatrics, 1988